HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Fanconi anemia of complementation group C — Clinical Guidelines

Overview

Fanconi anemia (FA) is an autosomal recessive disorder characterized by bone marrow failure, chromosomal instability, and increased cancer risk, often presenting with congenital malformations including ocular abnormalities and skeletal anomalies 1 4 6 7 10 11.

Diagnosis

Key Diagnostic Criteria:

- Cellular hypersensitivity to DNA crosslinking agents (e.g., mitomycin C) 8 - Increased spontaneous and clastogen-induced chromosome breakage 10 - Clinical features such as growth retardation, congenital malformations, and pancytopenia 5 10

Recommended Tests:

- Chromosome breakage studies 10 - Genetic testing for FA genes (e.g., FANCA, FANCC) 8 - Ophthalmological evaluation for ocular abnormalities 4 7

Management

First-Line Treatments:

- Bone marrow transplantation (BMT) for hematopoietic failure 3 9

Adjunctive Treatments:

- Supportive care for pancytopenia (e.g., transfusions, growth factors) 5 - Surveillance for malignancies and regular monitoring 9

Special Populations

Pediatrics:

- Early detection and intervention crucial due to growth retardation and developmental issues 5 10

Comorbidities:

- Consider bone marrow transplantation early in cases with severe pancytopenia 3 5

Key Recommendations

Perform chromosome breakage studies in patients with VACTERL association and hydrocephalus to rule out Fanconi anemia 10 11 (Evidence: Moderate)

Bone marrow transplantation should be considered as the primary treatment for hematopoietic failure in Fanconi anemia patients 3 9 (Evidence: Moderate)

Regular surveillance for malignancies and hematopoietic complications is essential in managing Fanconi anemia patients 9 (Evidence: Moderate)

References

1 Campello S, Cecconi F. Fanconi Anemia Genes, of Menders and Sweepers. Developmental cell 2016. link 2 Oka Y, Bekker-Jensen S, Mailand N. Ubiquitin-like protein UBL5 promotes the functional integrity of the Fanconi anemia pathway. The EMBO journal 2015. link 3 Ayas M, Eapen M, Le-Rademacher J, Carreras J, Abdel-Azim H, Alter BP et al.. Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2015. link 4 Aslan D, Ozdogan S, Onol M, Kaya Z, Gursel T. An unusual ocular manifestation in Fanconi anemia: congenital glaucoma. American journal of hematology 2005. link 5 Landmann E, Bluetters-Sawatzki R, Schindler D, Gortner L. Fanconi anemia in a neonate with pancytopenia. The Journal of pediatrics 2004. link 6 McGaughran J. Klippel-Feil anomaly in Fanconi anemia. Clinical dysmorphology 2003. link 7 Merriman M, Mora J, McGaughran J. Fanconi anemia and primary cataracts: first case. Ophthalmic genetics 2002. link 8 Cheng NC, van de Vrugt HJ, van der Valk MA, Oostra AB, Krimpenfort P, de Vries Y et al.. Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Human molecular genetics 2000. link 9 Berger R, Jonveaux P. Clonal chromosome abnormalities in Fanconi anemia. Hematology and cell therapy 1996. link 10 Rossbach HC, Sutcliffe MJ, Haag MM, Grana NH, Rossi AR, Barbosa JL. Fanconi anemia in brothers initially diagnosed with VACTERL association with hydrocephalus, and subsequently with Baller-Gerold syndrome. American journal of medical genetics 1996. link1096-8628(19960102)61:1<65::AID-AJMG12>3.0.CO;2-U) 11 Porteous ME, Cross I, Burn J. VACTERL with hydrocephalus: one end of the Fanconi anemia spectrum of anomalies?. American journal of medical genetics 1992. link 12 Berger R, Bussel A, Schenmetzler C. Somatic segregation and Fanconi anemia. Clinical genetics 1977. link

Fanconi anemia of complementation group C